12:00 AMFinancial Times
Superdrug owner considers delay to planned London IPO
Summary
AS Watson is weighing a delay to its planned London IPO, after targeting an autumn dual listing. The Hong Kong-based retailer is reassessing timing and market conditions for the float.
Why it matters
If a scaled, cash-generative health and beauty retailer hesitates, it signals tougher IPO pricing for consumer names and reduces near-term exit options across the sector.